Scientist.com werkt samen met Top Pharma bij de lancering van COMPLI™, een wereldwijde standaard voor compliance bij Human Biosample Acquisition
Inkoop van high-risk services wordt gemakkelijker met de nieuwe COMPLI™ feature van Scientist.com
SAN DIEGO–(BUSINESS WIRE)– Scientist.com, De grootste speler ter wereld voor het uitbesteden van wetenschappelijke dienstverlening maakt vandaag de lancering bekend van een wereldwijd proces voor ethisch verantwoorde inkoop van menselijke biosamples. Daarbij wordt gebruik gemaakt van de COMPLI™ functionaliteit. Die is gecreëerd in samenwerking met de belangrijkste farmaceutische bedrijven, suppliers en organisaties van biobanken, zoals de ASBB en UKCRC TCC. COMPLI™ introduceert een gemeenschappelijke, uitgebreide proces- en leveringsovereenkomst die het verkrijgen van menselijke biosamples beter regelt. Het doel is om biobanken en andere bekende leveranciers van menselijke biosamples in staat te stellen makkelijker contacten te onderhouden met onderzoekers in de farmaceutische en biotech-industrie en academici.
Scientist.com Partners with Top Pharma to Launch COMPLI™, a Global Compliance Standard for Human Biosample Acquisition
Sourcing of high-risk services made easier with Scientist.com’s new COMPLI™ feature
SAN DIEGO–(BUSINESS WIRE)– Scientist.com, the world’s leading marketplace for outsourced scientific services, today announced the launch of a global process for the ethical sourcing of human biosamples using its COMPLI™ functionality. Created in partnership with leading pharmaceutical companies, suppliers and biobank organizations such as the ESBB and UKCRC TCC, COMPLI™ introduces a common, comprehensive process and supply agreement supporting access to human biosamples. The goal is to enable biobanks and other well-known human sample suppliers to more easily connect with researchers in the pharmaceutical and biotech industries and academia.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170921005353/en/
“By simplifying and standardizing processes that previously took months, this initiative should shorten the research cycle and increase the pace of research,” stated Dr. Matharoo-Ball, President Elect, European, Middle Eastern and African Society for Biopreservation and BioBanking (ESBB). “We are pleased to support the development of a standard process that allows us all to rapidly utilise correctly consented human biosamples in an ethically compliant manner.”
Human biological samples, such as organs, tissues and genetic material, are increasingly being used in drug research, but until now there has been no common process governing their acquisition. The new COMPLI™ process helps researchers and suppliers adhere to internal and external (often legislative) procurement policies. It also ensures that appropriate donor consents have been obtained, tracked and communicated throughout the supply chain.
“It is still possible today to purchase human biological samples without any oversight whatsoever, putting all parties at considerable risk if samples are used inappropriately,” stated Matt McLoughlin, Senior Director of Compliance at Scientist.com. “The launch of COMPLI™ will significantly reduce the risks associated with using human samples. It will also enable researchers to gain faster access to critical research tools needed to respond to global health emergencies.”
COMPLI™ establishes a rigorous compliance and governance framework that increases visibility, traceability and control for the scientific research community. It is only available through the Scientist.com marketplace.
About Scientist.com
Scientist.com is the world’s leading scientific services marketplace. The marketplace simplifies research sourcing, saves time and money and provides access to innovative tools and technologies – while maintaining full compliance with an organization’s procurement policies. Scientist.com operates private marketplaces for most of the world’s major pharmaceutical companies and the US National Institutes of Health (NIH). Visit scientist.com to learn more.
Join Scientist.com on social media: YouTube, LinkedIn, Twitter, Facebook, Google+ and Instagram.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170921005353/en/
Contacts
Scientist.com
Sean Preci
Director of
Communications
858-455-1300
ext. 401
marketing@scientist.com